Tim Wright, Editor, Contract Pharma04.05.19
PCI Pharma Services is an integrated full service contract manufacturing organization (CMO) capable of taking compounds from the earliest stages of development through to commercialization. Its core services support each stage of the product lifecycle, including drug development, clinical trial supply, commercial launch and ongoing commercial supply.
Over the past decade, the Philadelphia-based CMO has undergone rapid growth of its services portfolio while expanding its global reach through acquisitions. In 2018, PCI bought Pharmaceutical Packaging Professionals (PPP) in Melbourne in March, providing new access to Australia and the wider Asia-Pacific region. Then in September it struck a deal for Sherpa Clinical Packaging in San Diego, CA, extending its presence across the U.S. to the West Coast and bolstering its presence in the biopharmaceutical development space.
During the year, PCI also underwent some internal change when it announced in July that Salim Haffar would join the company as its new chief executive officer. He brings to the chief e
Over the past decade, the Philadelphia-based CMO has undergone rapid growth of its services portfolio while expanding its global reach through acquisitions. In 2018, PCI bought Pharmaceutical Packaging Professionals (PPP) in Melbourne in March, providing new access to Australia and the wider Asia-Pacific region. Then in September it struck a deal for Sherpa Clinical Packaging in San Diego, CA, extending its presence across the U.S. to the West Coast and bolstering its presence in the biopharmaceutical development space.
During the year, PCI also underwent some internal change when it announced in July that Salim Haffar would join the company as its new chief executive officer. He brings to the chief e
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
